# LongGame

> LongGame is a VC fund backing Biotechnology and Life Science. See 6 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Total investments: 6
- Last investment: Jun 2026
- Lead investor: 17%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/longgame-vc
- Website: https://longgame.vc

LongGame is a venture capital and private equity principals platform.

## Contacts

5 contacts available for LongGame. Shizune tracks 1 team members at LongGame. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/longgame?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 5 | 83% |
| Life Science | 2 | 33% |
| Information Technology | 2 | 33% |
| Medical | 1 | 17% |
| Health Care | 1 | 17% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 4 | 67% |
| Series A | 2 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 3 | 50% |
| Israel | 1 | 17% |
| Switzerland | 1 | 17% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Will Harborne | General Partner | 4 | https://shizune.co/investors/profile/will-harborne |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| SyntaxBio | SyntaxBio develops CRISPR/Cas9-based, genetic programming platform that converts cells into biological computers using DNA-based instructions that read like lines of code. SyntaxBio's platform can program cells without the need for consistent external intervention. | $14.4M | Series A | Jun 21, 2026 |  |
| ImmuneBridge | ImmuneBridge is developing allogeneic immunotherapies for cancer. ImmuneBridge's key innovation fosters the development of immune stem cells obtained from cord blood and creates a fresh, adaptable, reliable, and plentiful cellular source for immunotherapies. They are currently looking for natural killer cell-based treatments for hematologicalcancers. They will then attack solid tumors using the special benefits of their cellular source. | $7.7M | Seed | Mar 23, 2026 |  |
| Adaptyv Biosystems | Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and nanofluidics. | $8M | Seed | Sep 19, 2025 |  |
| Renewal Bio | Renewal Bio is making advances in creating artificial wombs and stem-cell technology. |  | Seed | May 08, 2025 |  |
| Vincere Biosciences | Vincere Biosciences is a JLABS incubator company whose mission is to develop drugs to halt the progression of Parkinson's disease (PD). | $5M | Series A | Apr 01, 2025 |  |
| R3 Bio |  |  | Seed | Sep 01, 2024 |  |

6 of 6 investments shown.

## Co-investors
- [Healthspan Capital](https://shizune.co/investors/profile/healthspan-capital) — VC Fund, 2 deals together
- [Portal Innovations](https://shizune.co/investors/profile/portal-innovations) — VC Fund, 2 deals together
- [ACE Ventures](https://shizune.co/investors/profile/ace-ventures-4c4d) — VC Fund, 1 deal together
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund, 1 deal together
- [Astellas Venture Management](https://shizune.co/investors/profile/astellas-venture-management) — VC Fund, 1 deal together
- [Beiersdorf](https://shizune.co/investors/profile/beiersdorf) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does LongGame invest in?

LongGame invests primarily in Biotechnology, Life Science and Information Technology startups, most often at Seed and Series A stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact LongGame?

Public channels for LongGame include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at LongGame?

The team at LongGame includes Will Harborne (General Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co